James Treco - Net Worth and Insider Trading
James Treco Net Worth
The estimated net worth of James Treco is at least $0 dollars as of 2024-11-13. James Treco is the Director of Tonix Pharmaceuticals Holding Corp and owns about 2 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in James Treco's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Treco has not made any transactions after 2020-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Treco
James Treco Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Treco owns 1 companies in total, including Tonix Pharmaceuticals Holding Corp (TNXP) .
Click here to see the complete history of James Treco’s form 4 insider trades.
Insider Ownership Summary of James Treco
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TNXP | Tonix Pharmaceuticals Holding Corp | 2020-08-31 | director |
James Treco Latest Holdings Summary
James Treco currently owns a total of 1 stock. James Treco owns 2 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of August 31, 2020, with a value of $0.
Latest Holdings of James Treco
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TNXP | Tonix Pharmaceuticals Holding Corp | 2020-08-31 | 2 | 0.15 | 0 |
Holding Weightings of James Treco
James Treco Form 4 Trading Tracker
According to the SEC Form 4 filings, James Treco has made a total of 2 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 1 shares on August 31, 2020, which cost James Treco around $4,895.
Insider Trading History of James Treco
- 1
James Treco Trading Performance
GuruFocus tracks the stock performance after each of James Treco's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Treco is -34.79%. GuruFocus also compares James Treco's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Treco within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Treco's insider trading performs compared to the benchmark.
Performance of James Treco
James Treco Ownership Network
Ownership Network List of James Treco
Ownership Network Relation of James Treco
James Treco Owned Company Details
What does Tonix Pharmaceuticals Holding Corp do?
Who are the key executives at Tonix Pharmaceuticals Holding Corp?
James Treco is the director of Tonix Pharmaceuticals Holding Corp. Other key executives at Tonix Pharmaceuticals Holding Corp include director & 10 percent owner & Chief Executive Officer Seth Lederman , Chief Medical Officer Gregory M Sullivan , and Chief Administrative Officer Jessica Edgar Morris .
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tonix Pharmaceuticals Holding Corp (TNXP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tonix Pharmaceuticals Holding Corp Insider Transactions
James Treco Mailing Address
Above is the net worth, insider trading, and ownership report for James Treco. You might contact James Treco via mailing address: C/o Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., New York Ny 10022.